These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14032961)

  • 1. [Clinical aspects of the side-effects of a "mild" but effective neuroleptic agent (Melleril)].
    KIRCH GRABER D
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 91():412-45. PubMed ID: 14032961
    [No Abstract]   [Full Text] [Related]  

  • 2. [EFFECTS AND RESULTS OF PROLONGED TREATMENT WITH THIORIDAZINE (MELLERIL) IN MENTAL PATIENTS].
    HAMONEAU G; RUYNAT G; PLASSAT G
    Toulouse Med; 1964 Jun; 65():802-26. PubMed ID: 14187874
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of Melleril in the outpatient treatment of children].
    Majdecka A
    Ser Paedopsychiatr; 1965; (1):111-2. PubMed ID: 5847384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Note on the hospital use of thioridazine (Melleril) in acute and chronic diseases].
    FOSCHI F; MONACI G
    Riv Sper Freniatr Med Leg Alien Ment; 1962 Dec; 86():139-48. PubMed ID: 13958869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical therapeutic trials of the preparation "Melleril-retard"].
    Predescu V; Vianu I; Florescu D
    Neurol Psihiatr Neurochir; 1968; 13(4):289-94. PubMed ID: 5700979
    [No Abstract]   [Full Text] [Related]  

  • 6. [RESULTS OF THE USE OF MELLERIL IN CHILDREN UNDER AMBULATORY CONDITIONS].
    MAJDECKA A
    Neurol Neurochir Psychiatr Pol; 1964; 14():963-5. PubMed ID: 14293957
    [No Abstract]   [Full Text] [Related]  

  • 7. [Survey on Melleril (TP-21, a new phenothiazine derivative, from the standpoint of its use in psychiatry].
    KANDIC B; GRBESA B
    Vojnosanit Pregl; 1962 Sep; 19():619-20. PubMed ID: 13962172
    [No Abstract]   [Full Text] [Related]  

  • 8. [SYSTEMATIC COMBINATION OF FLUPHENAZINE AND THIORIDAZINE APROPOS OF 87 CASES].
    SCHNETZLER JP; LAMAND JC; CASSASSUCE J
    Ann Med Psychol (Paris); 1963 Nov; 121():580-8. PubMed ID: 14097259
    [No Abstract]   [Full Text] [Related]  

  • 9. [OPHTHALMOLOGIC EXAMINATION OF PATIENTS TREATED WITH MELLERIL].
    BECH K
    Nord Psykiatr Tidsskr; 1964; 18():575-8. PubMed ID: 14240159
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thioridazine (Melleril), a new neuroleptic for clinical and ambulant psychiatry].
    GROSS H; KAUPENY F; PLAVEC J; STEININGER E
    Wien Med Wochenschr; 1960 Oct; 110():844-50. PubMed ID: 13709013
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic-induced movement disorders: an overview.
    Sachdev PS
    Psychiatr Clin North Am; 2005 Mar; 28(1):255-74, x. PubMed ID: 15733622
    [No Abstract]   [Full Text] [Related]  

  • 12. Lesion therapy for Parkinson's disease and other movement disorders: update and controversies.
    Okun MS; Vitek JL
    Mov Disord; 2004 Apr; 19(4):375-89. PubMed ID: 15077235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Movement disorders in the emergency department].
    Erro ME; Gastón I; Navarro MC
    An Sist Sanit Navar; 2008; 31 Suppl 1():127-40. PubMed ID: 18528449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical results of the action of thioridazine in moderate and high doses during 4 years in 150 mental patients].
    Henne M; Martel J; Le Renard C; Bouju B
    Ann Med Psychol (Paris); 1966 Feb; 124(2):239-47. PubMed ID: 5909629
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of Keithon on bradykinesia induced by neuroleptic drugs].
    ROYER P; POIRE R; VANET G
    Ann Med Nancy; 1962; 1():376-82. PubMed ID: 13982882
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgery for movement disorders.
    Rezai AR; Machado AG; Deogaonkar M; Azmi H; Kubu C; Boulis NM
    Neurosurgery; 2008 Feb; 62 Suppl 2():809-38; discussion 838-9. PubMed ID: 18596424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A controlled clinical trial of thioridazine (melleril); a new phenothiazine derivative].
    HAUG JO
    Tidsskr Nor Laegeforen; 1959 Mar; 79(6):317-21 passim. PubMed ID: 13659465
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine.
    Wójcikowski J; Maurel P; Daniel WA
    Drug Metab Dispos; 2006 Mar; 34(3):471-6. PubMed ID: 16272405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients review: drug-induced movement disorders.
    Butković-Soldo S; Tomić S; Stimac D; Knezević L; Palić R; Jurić S; Marijanović K
    Coll Antropol; 2005 Dec; 29(2):579-82. PubMed ID: 16417164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the clinical heterogeneity of movement disorder in Parkinson disease].
    Liu ZL; Wang LM; Tao EX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):447-8. PubMed ID: 18359710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.